Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
2seventy Bio
2seventy Bio
(TSVT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lornoxicam
bone fractures
,
bunion
,
orthopedic procedures
,
alzheimer disease
,
migraine disorders
,
headache
,
pulpitis
,
endodontics
,
inguinal hernia
,
hernia
,
hemorrhoids
,
postoperative pain
,
acute coronary syndrome
,
syndrome
,
urinary bladder neoplasms
,
intravesical administration
,
cystitis
,
non-muscle invasive bladder neoplasms
,
acute pain
,
edema
,
trismus
,
knee osteoarthritis
,
osteoarthritis
,
arthralgia
,
pain
,
renal colic
,
colic
,
laparoscopic cholecystectomy
Cc5013
multiple myeloma
,
plasma cell neoplasms
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
recurrence
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
lymphoma
,
follicular lymphoma
,
mantle-cell lymphoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use